A new study into the effect of cannabis on Multiple Sclerosis has concluded that it doesn't slow down the progression of the disease as has been claimed in the past.
The drug is prescribed to sufferers to relieve pain and muscle spams.
The report's author Professor John Zijicek says trials like this are rare:
The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
A new study by the Multiple Sclerosis Society shows most people don't understand the condition.
More than 100,000 people suffer from the debilitating disease.
1 in 4 people thought disabled people exaggerated the extent of their condition, and many thought MS sufferers could not lead a normal life.
The mother of the late singer Amy Winehouse has spoken exclusively to ITV1's Daybreak about living with Multiple Sclerosis.
Janis Winehouse was first diagnosed 30 years ago and has learnt to cope with the disease. She says she was determined not to let MS get in the way of her life.
The Chair of the Committee of Public Accounts has said that the Health Department has not implemented its own plan for improving care for people with neurological conditions as set out in a 2005 report:
The Department [of Health] left the implementation to local health commissioners but gave them no leadership at all. It set no baselines and failed to monitor progress and so could not hold them to account where things went wrong. The present Government needs to understand what went wrong here for the future.
It comes as new figures suggest that emergency admissions have increased at the same time as NHS spending on such conditions has risen. In the past three years:
- Spending on neurological conditions is up by 40%
- Emergency admissions is up by 32%
- Readmissions within 28 days is up from 11.2% to 14%